**Core Concept**
Exercise-induced bronchial asthma is a condition characterized by bronchoconstriction and airway inflammation triggered by physical exertion. The underlying pathophysiological mechanism involves the release of inflammatory mediators and the activation of airway smooth muscle cells.

**Why the Correct Answer is Right**
The correct answer is a beta-2 agonist, specifically a short-acting beta-2 agonist (SABA) like salbutamol. SABA works by stimulating beta-2 adrenergic receptors in the airway smooth muscle, leading to bronchodilation and relief of symptoms. This is achieved through the activation of adenylate cyclase, which increases cyclic AMP levels and ultimately relaxes the airway smooth muscle.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because anticholinergics, such as ipratropium bromide, are more effective in chronic obstructive pulmonary disease (COPD) and do not provide rapid relief in exercise-induced bronchial asthma.
**Option B:** This option is incorrect because corticosteroids, such as fluticasone, are anti-inflammatory medications that require longer-term use and do not provide rapid relief in acute exercise-induced bronchial asthma.
**Option C:** This option is incorrect because theophylline is a methylxanthine bronchodilator that is not typically used for exercise-induced bronchial asthma due to its side effects and narrow therapeutic index.

**Clinical Pearl / High-Yield Fact**
In addition to SABA, patients with exercise-induced bronchial asthma should also be advised to use a spacer device when inhaling their medication, as this can improve lung deposition and efficacy.

**Correct Answer:** C. Theophylline is not the correct answer; the correct answer is not given as the options were incomplete.